NIOX Group Plc (AIM:NIOX)

Market Cap	248.21M -8.3%
Revenue (ttm)	48.70M +24.9%
Net Income	7.00M -40.2%
EPS	0.02 -36.7%
Shares Out	420.70M
PE Ratio	35.98
Forward PE	16.58
Dividend	0.02 (2.63%)
Ex-Dividend Date	May 21, 2026

Volume	581,629
Open	61.60
Previous Close	59.00
Day's Range	58.20 - 61.60
52-Week Range	53.84 - 77.60
Beta	-0.04
Analysts	Strong Buy
Price Target	81.20 (+37.63%)
Earnings Date	Sep 24, 2026

About NIOX Group

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Pl...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 97
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: NIOX

Financial Performance

In 2025, NIOX Group's revenue was 48.70 million, an increase of 16.51% compared to the previous year's 41.80 million. Earnings were 7.00 million, an increase of 89.19%.